About Us
Redefining the future of autoimmune disease treatment
At COUR, we are driven by a profound commitment to empowering people living with autoimmune disease. Led by a team of industry veterans with a proven track record of success in developing and commercializing biopharmaceuticals, we are positioned to deliver the next generation of disease-modifying therapies to patients with unprecedented speed.
Leadership
Board of directors
President and CEO
Lead Independent Director
Alpha Wave Global, LP Managing Director
Roche Venture Fund Senior Investment Director
Founder, Former President and CEO
Lumira Ventures Managing Director
Former Chairman, President, and Chief Executive Officer, Horizon Therapeutics; Senior Advisor, Amgen
Advisors
COUR’s scientific and medical advisors bring unique perspectives and expertise to drive the strategic direction and success for potentially life-changing technology.
Harvard Medical School
University of California, Davis
Northwestern University
University of Michigan
University of Miami
Yale University
University of Colorado
UC Davis